Trial Profile
Pharmacodynamic effect of supplementary vaccination with a single low and standard dose of hepatitis-B vaccine recombinant in healthy Iranian non-responder neonates
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs ABX 203 (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.